Top Authors

• Most frequent coverage on EXEL

• 
  Ohad Hammer (175 followers)

  • Top Biotech Picks for ASCO 2009 (Part II) (Wed, May 27)
  • Top Biotech Picks for ASCO 2009 (Part I) (Wed, May 27)
  • Micromet: More Reasons for Optimism (Mon, May 11)

  More by Ohad Hammer on EXEL »
• 
  Travis Johnson (24 followers)

  • Four Conviction Buys for Our Age of Uncertainty (Mon, Mar 19)
  • Exelixis' Special Purpose Entities A Far Cry From Enron (EXEL) (Tue, Apr 11)
  • Exelixis Upgraded With Good Reason (EXEL) (Wed, Mar 29)

  More by Travis Johnson on EXEL »
• 
  Alan Brochstein (707 followers)

  • Cancer Stocks: Tracking the Market (Mon, Jul 9)
  • Cancer Stocks: The Bleeding Slows (Mon, Jul 2)
  • Cancer Stocks Hammered Once Again (Tue, Jun 26)

  More by Alan Brochstein on EXEL »

• Most followed authors on EXEL

• 
  SA Editor Rachael Granby (2020 followers)

  • Wall Street Breakfast: Must-Know News (Fri, Jul 31)

  More by SA Editor Rachael Granby on EXEL »
• 
  Mike Havrilla (1924 followers)

  • ImmunoCellular's Promising Brain Cancer Vaccine (Wed, Oct 28)
  • Small Cap Stocks Battling Brain Cancer (Mon, Sep 7)
  • 40 Top Rated Emerging Bio-Pharma Stocks (Tue, Dec 23)

  More by Mike Havrilla on EXEL »
• 
  Marco Hickey (1311 followers)

  • Breakout Stocks on Huge Volume: Three Option Trades (Mon, Jul 27)

  More by Marco Hickey on EXEL »

• Newest authors on EXEL

• 
  Justin M. Hall (672 followers)

  • Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers (Sun, Sep 20)
  • Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up (Fri, Sep 11)

  More by Justin M. Hall on EXEL »
• 
  The Burrill Report (192 followers)

  • Two Potential Mega Biotech Deals Fuel Industry Hopes (Sun, May 31)
  • Exelixis Suggests Creativity in Finding Cash for Biotechs in Rough Times (Tue, May 26)

  More by The Burrill Report on EXEL »
• 
  Marco Hickey (1311 followers)

  • Breakout Stocks on Huge Volume: Three Option Trades (Mon, Jul 27)

  More by Marco Hickey on EXEL »

• Most commented on EXEL

• 
  Ohad Hammer (175 followers)

  • Top Biotech Picks for ASCO 2009 (Part II) (Wed, May 27)
  • Top Biotech Picks for ASCO 2009 (Part I) (Wed, May 27)
  • Micromet: More Reasons for Optimism (Mon, May 11)

  More by Ohad Hammer on EXEL »
• 
  Justin M. Hall (672 followers)

  • Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers (Sun, Sep 20)
  • Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up (Fri, Sep 11)

  More by Justin M. Hall on EXEL »
• 
  SA Editor Rachael Granby (2020 followers)

  • Wall Street Breakfast: Must-Know News (Fri, Jul 31)

  More by SA Editor Rachael Granby on EXEL »